REPORT DESCRIPTION
Trigeminal Neuralgia Treatment Market– Overview
Trigeminal neuralgia (TN), also known as tic douloureux, is a chronic pain disorder that affects the fifth
cranial or trigeminal nerve. It causes inflammatory conditions due to systemic diseases including Lyme
disease, sarcoidosis, and multiple sclerosis. There is also an association with collagen vascular diseases
including systemic lupus erythematosus and scleroderma. The condition is treated on an outpatient basis,
except till neurosurgical intervention is required. Its management must be customized individually, based
on the patient's general condition and age. However, the exact cause of the condition is unknown.
Trigeminal neuralgia treatment market can be subdivided into drug therapy and surgery. Trigeminal
neuralgia surgery is undertaken if medication causes troublesome side-effects or does not work. There are
three main types of surgeries, rhizotomy, stereotactic radiosurgery and microvascular decompression.
Rhizotomy is an outpatient procedure performed under general anesthesia. It involves destroying the fibers
within the trigeminal nerve that are carrying pain signals. Microvascular decompression is the most
curative and permanent surgery for trigeminal neuralgia treatment. It is usually offered to patients who are
not too older and are in reasonably good health.